Infarct Zone: a Novel Platform for Exosome Trade in Cardiac Tissue Regeneration

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Biotechnology

Background:

• Global incidence of coronary artery diseases (CADs), particularly myocardial infarction (MI), is increasing.
• Conventional therapies for MI have limitations, with concerning post-MI complications and recurrence rates.
• Molecular mechanisms underlying CAD pathogenesis and myocardial adaptation post-MI remain incompletely understood.

Purpose of the Study:

• To review current knowledge on cardiac exosome biology and therapeutic potential.
• To examine recent advancements in cardiac tissue engineering for CAD management.
• To discuss novel translational strategies combining tissue engineering and exosomes for cardiac regeneration.

Main Methods:

• Critical review of existing literature on cardiac exosomes and tissue engineering.
• Analysis of molecular signaling pathways involved in cardiac repair.
• Exploration of translational approaches for treating CADs.

Main Results:

• Exosome-mediated signaling in the infarct zone presents an emerging opportunity for cardiac regeneration.
• Cardiac tissue engineering offers promising therapeutic avenues for CAD management.
• Integration of exosome-based therapies with tissue engineering holds potential for enhanced cardiac repair.

Conclusions:

• Understanding exosome biology and tissue engineering is crucial for advancing cardiac regeneration.
• Combined strategies of tissue engineering and exosome therapy represent a novel translational approach for CADs.
• Further research is needed to fully harness the potential of these approaches for treating heart disease.